ClinicalTrials.gg
RecruitingNCT04861454Updated Nov 18, 2023

Brassiere Brow Suture and Internal Browpexy

An observational study in Eyelid Diseases, sponsored by Benha University. Recruiting at 1 site in United Arab Emirates. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-11-18.

Sponsored by Benha University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2024, 2 years 4 months ago, but the record still lists the study as recruiting.
  • Started Jan 2021; still recruiting 5 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

Brow ptosis is a common problem. internal browbexy and brassier suture are common surgical approach

Read the detailed description

upper eye transcutaneous blepharoplasty then combined browbexy and brassier suture are done

02

Conditions studied

  • Eyelid Diseases

Browse trials for

Keywords

  • blepharoplasty
  • browbexy
03

In context

Eyelid Diseases

26 studies on the registry are indexed under Eyelid Diseases; 4 are open to participants now.

Browse Eyelid Diseases studies →

Lead sponsor

Benha University is the lead sponsor of 365 studies on the registry; 67 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

At least 18 years with dermatochalasis

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • brow ptosis and dermatochalasis

Exclusion criteria

Exclusion Criteria:

  • eyelid diseases and previous surgery
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • surgical

    internal browbexy and brassier suture were done after blepharoplasty

06

What researchers measure

Primary outcomes

  1. global aesthetic scale

    calculate scale score from score 1 exceptional improvement to 5 worsening patient

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
  • INMC
    Abu Dhabi, 46266, United Arab Emirates
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2021 (actual). Primary completion is estimated for Jul 2024, 42 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 19, 2021
First posted
Apr 27, 2021
StartActual
Jan 10, 2021
Primary completionEst.
Jul 10, 2024
CompletionEst.
Jul 20, 2024
Last update
Nov 18, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04861454
Lead sponsor
Benha University
Responsible party
Tarek Roshdy mohamed Mahgoub ELhamaky (Associate Professor, Benha University) — Principal investigator
First posted
Apr 27, 2021
Start date
Jan 10, 2021
Primary completion
Jul 10, 2024 (estimated)
Completion
Jul 20, 2024 (estimated)
Last update
Nov 18, 2023

Study contacts

TAREK R ELHAMAKY, MD
Contact
dr_thamakyy@yahoo.com
503207889 ext. +971
TAREK ELHAMAKY
Contact
tarek elhamaky, MD
principal investigator · benha faculty of medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion